Neuronal ABHD6 Exacerbates Ischemic Brain Injury Through 2-AG Depletion and DDIT3/BNIP3-Dependent Autophagy Dysregulation

Every year, millions of people suffer from ischemic stroke, a condition where a blockage cuts off the blood supply to the brain. Without blood, brain cells are starved of oxygen and begin to die, leading to paralysis, speech difficulties, and sometimes death. While doctors can sometimes clear the blockage, the damage that follows is often permanent, and there are very few treatments available to protect the brain cells themselves during this crisis. Scientists have long known that the brain has its own internal defense system, a chemical network that helps calm inflammation and stop cells from dying when they are stressed. One key part of this system is a fatty molecule called 2-arachidonoylglycerol, or 2-AG for short. This molecule acts like a safety signal; when brain cells are injured, they release 2-AG to tell neighboring cells to slow down and protect themselves. However, for this signal to work correctly, it must be released and then cleared away at just the right time. If it lingers too long, it stops working, but if it is destroyed too quickly, the protection vanishes before it can help.

A team of researchers at Xijing Hospital and Fujian Medical University in China has uncovered a new piece of this puzzle. They discovered that after a stroke, a specific enzyme in the brain called ABHD6 becomes overactive. This enzyme acts like a pair of molecular scissors that cuts up the protective 2-AG signal. By destroying this signal too fast, the enzyme leaves the brain vulnerable to damage. But the researchers found something even more surprising: this same enzyme does not just destroy the chemical signal; it also turns off a vital cellular cleanup process called autophagy. Autophagy is how cells recycle their own damaged parts to stay healthy. When ABHD6 is active, it blocks this recycling, causing the cell to fill up with trash and eventually die. The study suggests that if scientists can stop this enzyme from working, they might be able to save brain cells after a stroke by keeping the protective signal alive and allowing the cells to clean up their own damage.

To find out what was happening, the scientists first looked at what occurs in the brain during a stroke. They created a model of stroke in mice by temporarily blocking the main artery that supplies blood to the brain, mimicking the event in humans. They also grew brain cells in a dish and deprived them of oxygen and glucose to see how they reacted in a controlled setting. In both the living mice and the lab-grown cells, they observed that the levels of the ABHD6 enzyme rose sharply shortly after the injury. Not only did the amount of the enzyme increase, but its activity also sped up, meaning it was cutting up the protective 2-AG molecules much faster than usual. This rapid destruction of the safety signal meant that the brain's natural defense system was being shut down right when it was needed most.

The team then tested whether stopping this enzyme could help. They used a drug called WWL70, which is designed to block ABHD6, and applied it to the mice and the brain cells. When the enzyme was blocked, the levels of the protective 2-AG signal stayed high. The brain cells that were treated with the drug survived much better than those that were not. In the mice, the area of the brain that died from the stroke was significantly smaller, and the animals showed much better recovery in their movement and coordination. They could walk better, balance more easily, and showed less anxiety-like behavior, which is common after a brain injury. To prove that this protection came specifically from the 2-AG signal, the researchers added a chemical that blocked the signal's receptors. When they did this, the benefits of the drug disappeared, confirming that the enzyme was hurting the brain by destroying this specific protective molecule.

However, the story did not end with just the chemical signal. The researchers wanted to know if ABHD6 was doing something else to harm the cells. They analyzed the genes inside the brain cells to see how the enzyme was changing their behavior. They found that when ABHD6 was active, it suppressed a specific pathway involving two proteins called DDIT3 and BNIP3. These proteins are known to be the triggers for autophagy, the cell's internal recycling system. When the enzyme was present, it kept these triggers turned off. As a result, the cells could not clear out their damaged parts. Under a powerful microscope, the scientists saw that the cells with active ABHD6 were full of waste and lacked the tiny recycling containers that healthy cells use to clean themselves. When they blocked the enzyme, the recycling system turned back on, the waste was cleared, and the cells survived the injury much more effectively.

To be sure this was happening in a living brain, the scientists used mice that had been genetically engineered to lack the ABHD6 enzyme entirely. These mice, which could not produce the enzyme at all, fared much better after a stroke than normal mice. Their brains showed higher levels of the protective signal and a much more active recycling system. The cells in their brains were cleaner, and the damage was far less severe. This confirmed that the enzyme itself was the problem, not just a side effect of the injury. The study also ruled out other possibilities, such as the idea that the enzyme was helping the brain by breaking down other fats or that the benefits came from a general reduction in inflammation. The protection was specifically tied to the enzyme's role in destroying the 2-AG signal and blocking the recycling pathway.

The findings offer a new way to think about treating stroke. For years, scientists have tried to boost the brain's natural defenses by stopping the main enzyme that breaks down the protective signal. However, that main enzyme is found everywhere in the brain, and stopping it completely can cause side effects like making animals too sleepy or overactive. The enzyme this team studied, ABHD6, is located in a very specific spot right next to where the signal is made. Because it works in such a precise location, blocking it might allow doctors to protect the brain without causing the broad side effects seen with other treatments. The research suggests that targeting this specific enzyme could restore the brain's ability to protect itself and clean up its own damage, offering a more precise and effective strategy for saving brain tissue after a stroke. While more work is needed to see if this approach works in humans, the study provides a clear map of how a single enzyme can tip the balance between life and death for brain cells during a crisis.